InvestorsHub Logo
icon url

Biobillionair

10/12/20 7:40 PM

#304634 RE: HDGabor #304630

G- Do you work for that Hungarian group that owns 26% stake in Hikma? Yes/No
BB
icon url

Number sleven

10/12/20 7:42 PM

#304635 RE: HDGabor #304630

HDG, Everything you just posted is absolutely true historically. Someone on the board posted the ruling in the GSK v Teva case. Somewhere in that ruling it was stated that knowledge of infringement was enough to prove inducement. To me it sounds like that could become a problem for the generic companies as everyone has knowledge of how the system works. Am I wrong.
Thanks for replying.
Sleven,
icon url

iryokabu

10/12/20 7:52 PM

#304639 RE: HDGabor #304630

What do you think about the below?

From Teva vs GSK ruling:

"The district court applied an incorrect legal standard, for precedent makes clear that when the provider of an identical product knows of and markets the same product for intended direct infringing activity, the criteria of induced infringement are met."